- |||||||||| nitazoxanide / Generic mfg.
Trial primary completion date: A Two Week Nitazoxanidebased Quadruple Regimen (clinicaltrials.gov) - Jan 3, 2018 P3, N=100, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Dec 2017 --> Dec 2022
- |||||||||| levofloxacin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date, Surgery: Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery (clinicaltrials.gov) - Oct 12, 2017 P3, N=576, Completed, Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017 Recruiting --> Completed | N=430 --> 576 | Trial primary completion date: Sep 2016 --> Mar 2017
- |||||||||| clarithromycin / Generic mfg.
Enrollment open: Hepys (clinicaltrials.gov) - Jun 20, 2017 P=N/A, N=2500, Recruiting, Trial primary completion date: Jun 2017 --> Dec 2017 Not yet recruiting --> Recruiting
- |||||||||| Xefo (lornoxicam) - Old API Wind / down, Takeda, Vesicare (solifenacin) / Astellas
Enrollment closed, Adverse events: Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? (clinicaltrials.gov) - May 23, 2017 P4, N=150, Active, not recruiting, Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Active, not recruiting
- |||||||||| AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Enrollment closed: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Apr 29, 2017 P=N/A, N=20, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||||||||| ceftriaxone / Generic mfg., levofloxacin / Generic mfg.
Enrollment open: Antibiotics to Decrease Post ERCP Cholangitis (clinicaltrials.gov) - Apr 20, 2017 P4, N=200, Recruiting, Initiation date: Apr 2016 --> Apr 2017 Not yet recruiting --> Recruiting
- |||||||||| levofloxacin / Generic mfg., fluconazole oral / Generic mfg., itraconazole / Generic mfg.
Clinical: Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients (clinicaltrials.gov) - Feb 17, 2017 P=N/A, N=1000, Recruiting, Initiation date: Dec 2016 --> Feb 2016 | Trial primary completion date: Mar 2017 --> Jul 2017 | Not yet recruiting --> Recruiting Trial primary completion date: Nov 2016 --> Nov 2017
|